Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Oct 30, 2014, after the close
10-Q filed Oct 30, 2014, 30 days after period end · 0000320017-14-000070
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Revenue | $4.12K | — | $4.43M | $2.18M |
| Net Income | -$16.97K | -$9.07K | -$8.41M | -$7.35M |
| EPS Diluted | -$0.48 |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$0.45 |
| -$0.64 |
| -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
